Home > Research > Publications & Outputs > De novo DNA methyltransferase activity in color...

Links

Text available via DOI:

View graph of relations

De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands

Research output: Working paperPreprint

Published

Standard

De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands. / Ali Masalmeh, R.H.; Rubio-Ramon, C.; Taglini, F. et al.
bioRxiv, 2019.

Research output: Working paperPreprint

Harvard

Ali Masalmeh, RH, Rubio-Ramon, C, Taglini, F, Higham, J, Davidson-Smith, H, Clark, R, Wills, J, Finch, AJ, Murphy, L & Sproul, D 2019 'De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands' bioRxiv. https://doi.org/10.1101/676346

APA

Ali Masalmeh, R. H., Rubio-Ramon, C., Taglini, F., Higham, J., Davidson-Smith, H., Clark, R., Wills, J., Finch, A. J., Murphy, L., & Sproul, D. (2019). De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands. bioRxiv. https://doi.org/10.1101/676346

Vancouver

Ali Masalmeh RH, Rubio-Ramon C, Taglini F, Higham J, Davidson-Smith H, Clark R et al. De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands. bioRxiv. 2019 Jun 21. doi: 10.1101/676346

Author

Ali Masalmeh, R.H. ; Rubio-Ramon, C. ; Taglini, F. et al. / De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands. bioRxiv, 2019.

Bibtex

@techreport{04441b18398a476da92811f672c19a91,
title = "De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands",
abstract = "The aberrant gain of DNA methylation at CpG islands (CGIs) is frequently observed in colorectal tumours and may silence the expression of tumour suppressors such as MLH1. Current models propose that these CGIs are targeted by de novo DNA methyltransferases (DNMTs) in a sequence-specific manner but this has not been tested. Using ectopically integrated CGIs, we find that aberrantly methylated CGIs are subject to low levels of de novo DNMT activity in colorectal cancer cells. By delineating DNMT targets, we find that instead de novo DNMT activity is targeted primarily to CGIs marked by the histone modification H3K36me3, a mark associated with transcriptional elongation. These H3K36me3 marked CGIs are heavily methylated in colorectal tumours and the normal colon suggesting that de novo DNMT activity at CGIs in colorectal cancer is focused on similar targets to normal tissues and not greatly remodelled by tumourigenesis.",
author = "{Ali Masalmeh}, R.H. and C. Rubio-Ramon and F. Taglini and J. Higham and H. Davidson-Smith and R. Clark and J. Wills and A.J. Finch and L. Murphy and D. Sproul",
year = "2019",
month = jun,
day = "21",
doi = "10.1101/676346",
language = "English",
publisher = "bioRxiv",
type = "WorkingPaper",
institution = "bioRxiv",

}

RIS

TY - UNPB

T1 - De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands

AU - Ali Masalmeh, R.H.

AU - Rubio-Ramon, C.

AU - Taglini, F.

AU - Higham, J.

AU - Davidson-Smith, H.

AU - Clark, R.

AU - Wills, J.

AU - Finch, A.J.

AU - Murphy, L.

AU - Sproul, D.

PY - 2019/6/21

Y1 - 2019/6/21

N2 - The aberrant gain of DNA methylation at CpG islands (CGIs) is frequently observed in colorectal tumours and may silence the expression of tumour suppressors such as MLH1. Current models propose that these CGIs are targeted by de novo DNA methyltransferases (DNMTs) in a sequence-specific manner but this has not been tested. Using ectopically integrated CGIs, we find that aberrantly methylated CGIs are subject to low levels of de novo DNMT activity in colorectal cancer cells. By delineating DNMT targets, we find that instead de novo DNMT activity is targeted primarily to CGIs marked by the histone modification H3K36me3, a mark associated with transcriptional elongation. These H3K36me3 marked CGIs are heavily methylated in colorectal tumours and the normal colon suggesting that de novo DNMT activity at CGIs in colorectal cancer is focused on similar targets to normal tissues and not greatly remodelled by tumourigenesis.

AB - The aberrant gain of DNA methylation at CpG islands (CGIs) is frequently observed in colorectal tumours and may silence the expression of tumour suppressors such as MLH1. Current models propose that these CGIs are targeted by de novo DNA methyltransferases (DNMTs) in a sequence-specific manner but this has not been tested. Using ectopically integrated CGIs, we find that aberrantly methylated CGIs are subject to low levels of de novo DNMT activity in colorectal cancer cells. By delineating DNMT targets, we find that instead de novo DNMT activity is targeted primarily to CGIs marked by the histone modification H3K36me3, a mark associated with transcriptional elongation. These H3K36me3 marked CGIs are heavily methylated in colorectal tumours and the normal colon suggesting that de novo DNMT activity at CGIs in colorectal cancer is focused on similar targets to normal tissues and not greatly remodelled by tumourigenesis.

U2 - 10.1101/676346

DO - 10.1101/676346

M3 - Preprint

BT - De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands

PB - bioRxiv

ER -